Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$5.23 0.10 (1.95%) as of 4:30 Fri 10/24


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 298.53(M)
Last Volume: 97,895 Avg Vol: 97,152
52 Week Range: $0.8406 - $5.94
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 5
Insider 3/6 Months : 5.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 6,000 45,969 69,569
Total Buy Value $0 $17,420 $52,303 $115,200
Total People Bought 0 2 4 5
Total Buy Transactions 0 2 6 20
Total Shares Sold 22,706 22,706 132,360 157,360
Total Sell Value $145,102 $145,102 $242,248 $318,748
Total People Sold 2 2 3 4
Total Sell Transactions 2 2 5 7
End Date 2025-07-27 2025-04-25 2024-10-25 2023-10-26

   
Records found: 318
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Czirr James C 10% Owner   –       –       •   2025-10-22 4 S $4.93 $246,800 D/D (50,000) 5,872,207     -
   Lewis Joel President and CEO   •       •      –    2025-09-12 4 AS $6.36 $89,048 D/D (14,000) 832,592 -3%     
   Lewis Joel President and CEO   •       •      –    2025-09-12 4 OE $2.39 $33,460 D/D 14,000 846,592     -
   Callicutt Jack W Chief Financial Officer   •       –      –    2025-09-12 4 AS $6.44 $56,054 D/D (8,706) 7,614 -3%     
   Callicutt Jack W Chief Financial Officer   •       –      –    2025-09-12 4 OE $1.37 $11,927 D/D 8,706 16,320     -
   Eldred Kary   •       •      –    2025-07-21 4 B $2.93 $2,925 D/D 1,000 64,682 0.01 87%     
   Freeman Kevin D   •       •      –    2025-07-17 4 B $2.90 $14,495 D/D 5,000 49,769 0.01 78%     
   Czirr James C 10% Owner   –       –       •   2025-06-06 4 OE $0.89 $699,344 D/D 323,125 1,045,541     -
   Czirr James C 10% Owner   –       –       •   2025-03-31 4 A $6.00 $6,000 D/D 1,000 722,416     -
   Lewis Joel President and CEO   •       •      –    2025-03-03 4 A $1.57 $88,579 D/D 56,420 832,592     -
   Czirr James C 10% Owner   –       –       •   2025-02-04 4 GD $0.00 $0 D/D 10,000 721,416     -
   Czirr James C 10% Owner   –       –       •   2025-02-03 4 GD $0.00 $0 D/D 10,000 731,416     -
   Uihlein Richard E   •       •       •   2025-01-23 4 A $1.23 $40,000 D/D 32,520 10,301,271     -
   Shlevin Harold H.   •       •      –    2024-12-30 4 B $1.16 $7,540 D/D 6,500 15,206 0.01 26%     
   Eldred Kary   •       •      –    2024-12-24 4 B $0.82 $11,045 D/D 13,469 63,682 0.01 87%     
   Zordani Richard A. Jr.   •       •      –    2024-12-24 4 B $0.82 $8,164 D/D 10,000 42,083 0.01 87%     
   Freeman Kevin D   •       •      –    2024-12-24 4 B $0.81 $8,134 D/D 10,000 44,769 0.01 87%     
   Lewis Joel President and CEO   •       •      –    2024-12-23 4 AS $0.89 $49,610 D/D (56,000) 897,012 53%     
   Lewis Joel President and CEO   •       •      –    2024-12-23 4 OE $0.00 $0 D/D 56,000 953,012     -
   Callicutt Jack W Chief Financial Officer   •       •      –    2024-12-23 4 AS $0.89 $35,492 D/D (40,000) 7,614 53%     
   Callicutt Jack W Chief Financial Officer   •       •      –    2024-12-23 4 OE $0.00 $0 D/D 40,000 47,614     -
   Jamil Khurram Chief Medical Officer   •       •      –    2024-12-23 4 AS $0.88 $12,044 D/D (13,654) 26,346 53%     
   Jamil Khurram Chief Medical Officer   •       •      –    2024-12-23 4 OE $0.00 $0 D/D 40,000 40,000     -
   Eldred Kary   •       •      –    2024-10-23 4 B $2.60 $1,300 D/D 500 50,213 0.01 -38%     
   Freeman Kevin D   •       •      –    2024-10-17 4 B $2.64 $3,432 D/D 1,300 34,769 0.01 -41%     
  318 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us